FDA Warning Letter: Curaleaf, Inc.
FDA warns Curaleaf, Inc. over illegal sales of unapproved CBD products with claims to treat cancer, Alzheimer’s disease, opioid withdrawal,…
Read More
FDA Approves 12-Month Heartworm Injection for Dogs
On July 2, 2019, the FDA-CVM announced approval of ProHeart 12 (moxidectin), a 12-month extended-release injection for dogs age 12…
Read More
FDA Issues Status Report in Canine Heart Disease Investigation
Last week, the FDA provided an update to its ongoing investigation into reports of canine dilated cardiomyopathy (DCM) in dogs…
Read More
Mike Uckele, Elan Sudberg Elected to NASC Board of Directors
Congratulations to Mike Uckele of Uckele Health and Nutrition, Inc. and Élan Sudberg of Alkemist Labs, both of whom were…
Read More
NASC Members Raise $42k for VIK9s, Fund 43 Ballistic K9 Vests
The nonprofit organization Vested Interest in K9s (VIK9s) was the beneficiary of fundraising efforts by members of the National…
Read More
USEF: Positive Cannabinoids Tests to Result in GR4 Violations
The United States Equine Federation has announced that beginning September 1, 2019, horses competing under USEF rules who test positive…
Read More
NASC & UNPA Sign Memorandum of Understanding
The United Natural Products Alliance (UNPA) has signed a Memorandum of Understanding (MOU) agreement with the National Animal Supplement Council…
Read More
FDA Approves Second Insulin Drug for Diabetic Dogs
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) announced today that it has approved the drug ProZinc…
Read More
Hemp & CBD in Pet Supplements
To better understand the legal limbo pet supplements containing hemp and CBD exist in—and the boundaries the NASC has created…
Read More
FDA Approves Pexion for Dogs Scared by Noise
The U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) announced today that it has approved the drug Pexion…
Read More